S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Imagine360 and Health Rosetta Unveil Choice360 to Curb Rising Health Costs

With PwC projecting a 9% surge in commercial healthcare costs for 2027—the sharpest increase in nearly two decades—Imagine360 and Health Rosetta have launched Choice360. This integrated health plan aims to provide self-funded employers a transparent, advisor-led alternative to traditional coverage models facing mounting financial pressure.

Imagine360 and Health Rosetta Unveil Choice360 to Curb Rising Health Costs
Photo: Bio & News

The new offering, set for the January 2027 plan year, emerged following a rigorous evaluation of Imagine360’s administrative services against Health Rosetta’s Nautilus framework. By standardizing plan design and integrating partners across primary care, mental health, and oncology, the companies intend to strip away the complexity often associated with high-performing health plans.

Jeff Bak, CEO of Imagine360, noted that the current system fails to offer sustainable value to families, necessitating a shift toward more predictable, performance-based pricing. The collaboration provides advisors with tools for implementation, analytics, and compliance, while maintaining the flexibility to incorporate traditional network options for employers transitioning to new strategies. Choice360 will officially debut at RosettaFest 2026, marking a strategic attempt to scale proven cost-containment measures to a wider market of self-funded businesses.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!